(Total Views: 146)
Posted On: 01/31/2022 1:39:12 PM
Post# of 21237
$GTCH Their Pending FDA Approval Could Become a Huge Catalyst:
“We plan to offer the technology for personal, hospitals and clinics usage and seeking to comply with the industry’s standards and regulations. FDA approval means that the FDA has formally approved the qTerm product to be safe and effective for market and sale in the U.S.” – Danny Rittman, CTO of GBT Technologies(1)
How big of a potential catalyst you ask? Game-changing is not even close to the right word.
According to a research report by Market Research Future (MRFR), the smart medical devices market is estimated to reach $23.50 billion by 2027 at a compound annual growth rate (CAGR) of 23.5%.(3)
Are you beginning to see the massive potential here? At a tiny $5.2 million market cap (1/19/22) just a measly 1% of that market could possibly catapult GTCH to some very impressive potential gains. https://techmarketreporter.com/ai-small-cap-c...402428baac $MRNA $IBB $EVAX $ICAD $IRIX $MRNA $AMGN $GILD
“We plan to offer the technology for personal, hospitals and clinics usage and seeking to comply with the industry’s standards and regulations. FDA approval means that the FDA has formally approved the qTerm product to be safe and effective for market and sale in the U.S.” – Danny Rittman, CTO of GBT Technologies(1)
How big of a potential catalyst you ask? Game-changing is not even close to the right word.
According to a research report by Market Research Future (MRFR), the smart medical devices market is estimated to reach $23.50 billion by 2027 at a compound annual growth rate (CAGR) of 23.5%.(3)
Are you beginning to see the massive potential here? At a tiny $5.2 million market cap (1/19/22) just a measly 1% of that market could possibly catapult GTCH to some very impressive potential gains. https://techmarketreporter.com/ai-small-cap-c...402428baac $MRNA $IBB $EVAX $ICAD $IRIX $MRNA $AMGN $GILD
(0)
(0)
